Insider Transactions in Q1 2021 at Biolife Solutions Inc (BLFS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2021
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
7,511
+3.45%
|
-
|
|
Feb 08
2021
|
Marcus Schulz Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,912
+6.78%
|
-
|
|
Feb 08
2021
|
Sarah Aebersold Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,795
+11.8%
|
-
|
|
Feb 08
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,196
+13.19%
|
-
|
|
Feb 08
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,891
+2.57%
|
-
|
|
Feb 08
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
23,336
+22.98%
|
-
|
|
Feb 08
2021
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,157
+7.04%
|
-
|
|
Feb 05
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,000
-1.2%
|
$1,600,000
$40.9 P/Share
|
|
Feb 04
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
18,483
-9.29%
|
$739,320
$40.02 P/Share
|
|
Feb 04
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,483
+8.5%
|
$18,483
$1.12 P/Share
|
|
Feb 04
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,538
-0.26%
|
$341,520
$40.65 P/Share
|
|
Feb 02
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
18,484
-9.29%
|
$739,360
$40.23 P/Share
|
|
Feb 02
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,484
+8.5%
|
$18,484
$1.12 P/Share
|
|
Feb 01
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
18,484
-9.29%
|
$702,392
$38.71 P/Share
|
|
Feb 01
2021
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,484
+8.5%
|
$18,484
$1.12 P/Share
|
|
Jan 25
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
50,000
-1.48%
|
$2,050,000
$41.58 P/Share
|
|
Jan 22
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,811
-0.87%
|
$1,252,062
$42.48 P/Share
|
|
Jan 20
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,182
-0.85%
|
$1,196,462
$41.03 P/Share
|
|
Jan 19
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,000
-1.15%
|
$1,600,000
$40.3 P/Share
|
|
Jan 15
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,338
-0.84%
|
$1,173,520
$40.62 P/Share
|
|
Jan 14
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,152
-0.63%
|
$952,536
$43.08 P/Share
|
|
Jan 12
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
2,000
-5.11%
|
$82,000
$41.01 P/Share
|
|
Jan 12
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,435
-0.24%
|
$337,400
$40.4 P/Share
|
|
Jan 11
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
80,000
-0.74%
|
$3,200,000
$40.23 P/Share
|
|
Jan 08
2021
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
293
-0.74%
|
$11,427
$39.01 P/Share
|
|
Jan 07
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,000
-0.82%
|
$1,170,000
$39.55 P/Share
|
|
Jan 06
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,075
-0.41%
|
$618,075
$41.53 P/Share
|
|
Jan 05
2021
|
Walter Villiger > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,948
-0.51%
|
$795,816
$42.54 P/Share
|